Register
Medical professional points at detailed brain imaging scans on a digital diagnostic display

RESEARCH

19 Jun 2026

BioNTech's Oncology Push Signals a New Era

BioNTech showcased a sweeping oncology pipeline at ASCO 2026, signaling a serious pivot toward multi-product cancer status.

Moderna headquarters building exterior with bold red logo signage mounted above glass entrance doors

INNOVATION

17 Jun 2026

Moderna's mRNA Flu Shot Gets Its FDA Moment

FDA reviews Moderna's mRNA flu vaccine June 18, with an August 5 decision due, as cancer trial data shows durable 49% risk reduction

Moderna company name in red lettering on the upper facade of a beige corporate building under a cloudy sky

PARTNERSHIPS

16 Jun 2026

Propionic Acidemia Just Got Pharma's Attention

Moderna and Recordati join forces on mRNA-3927, targeting propionic acidemia with a $160M+ deal covering clinical and commercial rights

BioNTech office and laboratory building sign displaying address 12 outside a modern corporate campus

INVESTMENT

15 Jun 2026

Why BioNTech Is Breaking Itself In Two

BioNTech will spin off next-gen mRNA research into an independent firm led by its co-founders, separating science from commercial oncology

Denali Therapeutics headquarters with the company name on a glass-fronted building under a clear blue sky

INNOVATION

12 Jun 2026

Denali Wins FDA Nod for Brain-Barrier Drug

Denali Therapeutics wins FDA accelerated approval for AVLAYAH, the first oligonucleotide to cross the blood-brain barrier via transferrin ...

Laboratory robotic arm between two Opentrons workstations with sample tubes and a BioTek reader nearby

TECHNOLOGY

10 Jun 2026

Meet the AI Platform Redesigning mRNA Delivery

Toronto's LUMI-lab screened 1,700+ lipid nanoparticles autonomously, finding a new class of mRNA delivery boosters that outperform COVID v...

topics on the agenda

ESTABLISHING AN “RNA COOPERATIVE” TO CO-DEVELOP AN mRNA VACCINE

Day 1: WEDNESDAY, 22 JULY, 2026

09:00 - 09:25

NOVEL APPROACH TO IDENTIFY BIOMARKERS FOR mRNA-BASED THERAPEUTICS AND VACCINES

Day 1: WEDNESDAY, 22 JULY, 2026

09:30 - 09:55

PANEL DISCUSSION ON HARNESSING DATA FOR THE DEVELOPMENT OF SAFE AND RELIABLE RNA THERAPEUTICS

Day 1: WEDNESDAY, 22 JULY, 2026

11:00 - 11:30

View more topics

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.